Next Article in Journal
An Unusual Case of Staphylococcus pasteuri Osteomyelitis
Previous Article in Journal
Gene Expression Tryptophan Aspartate Coat Protein in Determining Latent Tuberculosis Infection Using Immunocytochemistry and Real Time Polimerase Chain Reaction
 
 
Infectious Disease Reports is published by MDPI from Volume 12 Issue 3 (2020). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with PAGEPress.
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Insights into the Clinical Management of Carbapenem-Resistant Gram-Negative Infections: An Italian Retrospective Clinical Chart Review

1
Severe and Immunocompromised-associated Infection Unit, National Institute for Infectious Diseases Lazzaro Spallanzani, Scientific Institute for Treatment and Inpatient Care, Rome, Italy
2
Shionogi B.V., London, UK
3
University College of London, Institute for Global Health, London, UK
4
Shionogi Srl, Rome, Italy
5
Shionogi Inc., Florham Park, NJ, USA
6
Microbiology Unit, National Institute for Infectious Diseases Lazzaro Spallanzani, IRCCS, Rome, Italy
7
Clinical and Research Department, National Institute for Infectious Diseases Lazzaro Spallanzani, Scientific Institute for Treatment and Inpatient Care, Rome, Italy
*
Author to whom correspondence should be addressed.
Infect. Dis. Rep. 2020, 12(2), 8510; https://doi.org/10.4081/idr.2020.8510
Submission received: 21 February 2020 / Revised: 22 February 2020 / Accepted: 12 May 2020 / Published: 5 August 2020

Abstract

There is a lack of consensus regarding management of infections with carbapenem- resistant Gram-negative (CR-GN) pathogens. This study comprised a medical chart review to assess patient management in a high CR prevalence setting. Data was collated retrospectively from medical records of patients hospitalized between November 1st, 2015 and October 31st, 2016. Of 29 patients, 66% had respiratory tract infections. Median duration of hospitalization was 28 days and ~50% of patients were admitted to the intensive care unit, with 77% remaining for >2 weeks. Median time to obtain respiratory culture results was 5 days. Isolation of patients with diagnosed CR-GN infection took ≥5 days in >50% of patients. A majority (76%) of patients received ≥1 antibiotic before providing a specimen for culture; a total of 17 antibiotic treatments were used. Overall, 72% of patients, and 68% of those with respiratory infections, were discharged alive; 38% were discharged without further antibiotics. The difficulties in achieving effective management in patients with CR-GN infections are largely due to complex co-morbidities, a history of prior antibiotic treatment, and multiple referrals across health care facilities.
Keywords: antibiotic resistance; carbapenem resistance; multi-drug resistance; Gram-negative bacteria; clinical management antibiotic resistance; carbapenem resistance; multi-drug resistance; Gram-negative bacteria; clinical management

Share and Cite

MDPI and ACS Style

Granata, G.; Manissero, D.; Oppia, M.V.; Tone, K.; Cai, B.; Longshaw, C.; Venditti, C.; Petrosillo, N. Insights into the Clinical Management of Carbapenem-Resistant Gram-Negative Infections: An Italian Retrospective Clinical Chart Review. Infect. Dis. Rep. 2020, 12, 8510. https://doi.org/10.4081/idr.2020.8510

AMA Style

Granata G, Manissero D, Oppia MV, Tone K, Cai B, Longshaw C, Venditti C, Petrosillo N. Insights into the Clinical Management of Carbapenem-Resistant Gram-Negative Infections: An Italian Retrospective Clinical Chart Review. Infectious Disease Reports. 2020; 12(2):8510. https://doi.org/10.4081/idr.2020.8510

Chicago/Turabian Style

Granata, Guido, Davide Manissero, Maria Vittoria Oppia, Keiko Tone, Bin Cai, Christopher Longshaw, Carolina Venditti, and Nicola Petrosillo. 2020. "Insights into the Clinical Management of Carbapenem-Resistant Gram-Negative Infections: An Italian Retrospective Clinical Chart Review" Infectious Disease Reports 12, no. 2: 8510. https://doi.org/10.4081/idr.2020.8510

Article Metrics

Back to TopTop